Bortezomib administration with severe hyperbilirubinemia caused by hepatic plasma cell infiltration: a case report

Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):159-61. doi: 10.1016/j.clml.2012.09.005. Epub 2012 Oct 17.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Biopsy
  • Boronic Acids / administration & dosage*
  • Boronic Acids / adverse effects
  • Bortezomib
  • Female
  • Humans
  • Hyperbilirubinemia / etiology*
  • Liver / drug effects
  • Liver / pathology*
  • Middle Aged
  • Multiple Myeloma / complications*
  • Multiple Myeloma / diagnosis
  • Multiple Myeloma / drug therapy
  • Plasma Cells / pathology*
  • Pyrazines / administration & dosage*
  • Pyrazines / adverse effects

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib